These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24949416)

  • 41. Comparison of velocity- and acceleration-selective arterial spin labeling with [15O]H2O positron emission tomography.
    Schmid S; Heijtel DF; Mutsaerts HJ; Boellaard R; Lammertsma AA; Nederveen AJ; van Osch MJ
    J Cereb Blood Flow Metab; 2015 Aug; 35(8):1296-303. PubMed ID: 25785831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemilaterally masked arterial spin labeling by intentional magnetic field changes in the labeling area due to placement of material with high susceptibility.
    Hagiwara H; Nakajima Y; Ikegami T; Kinno Y; Kumada M
    PLoS One; 2018; 13(7):e0200648. PubMed ID: 30001396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebral vascular response to hypercapnia: determination with perfusion MRI at 1.5 and 3.0 Tesla using a pulsed arterial spin labeling technique.
    Nöth U; Meadows GE; Kotajima F; Deichmann R; Corfield DR; Turner R
    J Magn Reson Imaging; 2006 Dec; 24(6):1229-35. PubMed ID: 17094105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intra- and interscanner reliability and reproducibility of 3D whole-brain pseudo-continuous arterial spin-labeling MR perfusion at 3T.
    Wu B; Lou X; Wu X; Ma L
    J Magn Reson Imaging; 2014 Feb; 39(2):402-9. PubMed ID: 23723043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal relation between blood pressure, antihypertensive use and cerebral blood flow, using arterial spin labelling MRI.
    van Dalen JW; Mutsaerts HJ; Petr J; Caan MW; van Charante EPM; MacIntosh BJ; van Gool WA; Nederveen AJ; Richard E
    J Cereb Blood Flow Metab; 2021 Jul; 41(7):1756-1766. PubMed ID: 33325767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arterial spin-labeling evaluation of cerebrovascular reactivity to acetazolamide in healthy subjects.
    Inoue Y; Tanaka Y; Hata H; Hara T
    AJNR Am J Neuroradiol; 2014 Jun; 35(6):1111-6. PubMed ID: 24371025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced perfusion in normal-appearing white matter in mild to moderate hypertension as revealed by 3D pseudocontinuous arterial spin labeling.
    Wang T; Li Y; Guo X; Huang D; Ma L; Wang DJ; Lou X
    J Magn Reson Imaging; 2016 Mar; 43(3):635-43. PubMed ID: 26256700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans.
    Ye FQ; Berman KF; Ellmore T; Esposito G; van Horn JD; Yang Y; Duyn J; Smith AM; Frank JA; Weinberger DR; McLaughlin AC
    Magn Reson Med; 2000 Sep; 44(3):450-6. PubMed ID: 10975898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of neonate haematocrit variability on the longitudinal relaxation time of blood: Implications for arterial spin labelling MRI.
    De Vis JB; Hendrikse J; Groenendaal F; de Vries LS; Kersbergen KJ; Benders MJ; Petersen ET
    Neuroimage Clin; 2014; 4():517-25. PubMed ID: 24818078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of cerebral perfusion and cerebrovascular reserve using Turbo-QUASAR arterial spin labeling MRI.
    Zhao MY; Václavů L; Petersen ET; Biemond BJ; Sokolska MJ; Suzuki Y; Thomas DL; Nederveen AJ; Chappell MA
    Magn Reson Med; 2020 Feb; 83(2):731-748. PubMed ID: 31513311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absolute quantification of cerebral blood flow: correlation between dynamic susceptibility contrast MRI and model-free arterial spin labeling.
    Knutsson L; van Westen D; Petersen ET; Markenroth Bloch K; Holtås S; Ståhlberg F; Wirestam R
    Magn Reson Imaging; 2010 Jan; 28(1):1-7. PubMed ID: 19695822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease.
    Zhang Q; Stafford RB; Wang Z; Arnold SE; Wolk DA; Detre JA
    J Alzheimers Dis; 2012; 32(3):677-87. PubMed ID: 22886015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial volume correction of multiple inversion time arterial spin labeling MRI data.
    Chappell MA; Groves AR; MacIntosh BJ; Donahue MJ; Jezzard P; Woolrich MW
    Magn Reson Med; 2011 Apr; 65(4):1173-83. PubMed ID: 21337417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of tissue T
    Debacker CS; Daoust A; Köhler S; Voiron J; Warnking JM; Barbier EL
    Magn Reson Med; 2017 Apr; 77(4):1656-1664. PubMed ID: 27136322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
    Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
    Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arterial Spin Labeling MRI for Quantitative Assessment of Cerebral Perfusion Before and After Cerebral Revascularization in Children with Moyamoya Disease.
    Ha JY; Choi YH; Lee S; Cho YJ; Cheon JE; Kim IO; Kim WS
    Korean J Radiol; 2019 Jun; 20(6):985-996. PubMed ID: 31132824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regional reliability of quantitative signal targeting with alternating radiofrequency (STAR) labeling of arterial regions (QUASAR).
    Tatewaki Y; Higano S; Taki Y; Thyreau B; Murata T; Mugikura S; Ito D; Takase K; Takahashi S
    J Neuroimaging; 2014; 24(6):554-561. PubMed ID: 25370338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility study of exploring a T₁-weighted dynamic contrast-enhanced MR approach for brain perfusion imaging.
    Zhang Y; Wang J; Wang X; Zhang J; Fang J; Jiang X
    J Magn Reson Imaging; 2012 Jun; 35(6):1322-31. PubMed ID: 22314848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arterial spin labeling MR imaging for the clinical detection of cerebellar hypoperfusion in patients with spinocerebellar degeneration.
    Ikawa M; Kimura H; Kitazaki Y; Sugimoto K; Matsunaga A; Hayashi K; Yamamura O; Tsujikawa T; Hamano T; Yoneda M; Okazawa H; Nakamoto Y
    J Neurol Sci; 2018 Nov; 394():58-62. PubMed ID: 30216759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantification of cerebral blood flow in healthy volunteers and type 1 diabetic patients: comparison of MRI arterial spin labeling and [(15)O]H2O positron emission tomography (PET).
    van Golen LW; Kuijer JP; Huisman MC; IJzerman RG; Barkhof F; Diamant M; Lammertsma AA
    J Magn Reson Imaging; 2014 Dec; 40(6):1300-9. PubMed ID: 24214919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.